Serine protease hepsin (229-237)

Serine protease hepsin (229-237) is a synthetic peptide fragment derived from the active site region of hepsin, a type II transmembrane serine protease predominantly expressed in liver and prostate tissues. As a short, well-defined peptide sequence, it serves as a valuable molecular tool for probing the structure, function, and substrate specificity of the hepsin enzyme family. The 229-237 region encompasses amino acids critical for catalytic activity and substrate interaction, making it highly relevant for research focused on protease biology, enzymatic regulation, and the development of protease-targeted assays. Its defined sequence and biochemical stability enable precise experimental manipulation in a variety of biochemical and cellular contexts.

Enzyme substrate profiling: The peptide corresponding to the 229-237 region of hepsin is frequently employed in substrate specificity studies to elucidate the catalytic preferences of hepsin and related serine proteases. By serving as a defined substrate in enzymatic assays, it allows researchers to monitor cleavage efficiency, map active site interactions, and characterize the kinetic parameters of proteolytic activity. Such applications are essential for understanding the molecular determinants of substrate recognition and for identifying sequence motifs critical for hepsin function.

Protease inhibitor screening: The synthetic peptide is instrumental in high-throughput screening platforms designed to identify and characterize inhibitors of hepsin activity. By incorporating the peptide into fluorogenic or chromogenic assay systems, investigators can quantitatively assess the efficacy of small molecules, peptides, or biologics in blocking substrate cleavage. This approach supports the discovery and optimization of selective inhibitors for biochemical research, target validation, and mechanistic studies of protease regulation.

Epitope mapping and antibody validation: The defined sequence of the 229-237 peptide fragment enables its use in epitope mapping experiments, particularly for the generation and validation of antibodies against hepsin. Researchers utilize the peptide to verify antibody specificity, assess cross-reactivity, and map linear epitopes within the protease domain. These applications are pivotal for the development of reliable immunodetection reagents and for advancing research on hepsin's cellular localization and expression patterns.

Structural and biophysical studies: The peptide serves as a model system for investigating the conformational dynamics and structural features of the hepsin active site. Through techniques such as nuclear magnetic resonance (NMR) spectroscopy, circular dichroism (CD), or X-ray crystallography, scientists can analyze the secondary structure, folding properties, and interaction interfaces of the peptide. Such studies contribute to a deeper understanding of protease architecture and inform the rational design of modulators or probes targeting the hepsin active site.

Peptide-based assay development: The hepsin (229-237) fragment is a valuable component in the design of custom biochemical assays for quantifying proteolytic activity or monitoring enzyme kinetics. Its incorporation into synthetic substrates, biosensors, or immobilized assay platforms enables sensitive and specific detection of hepsin-mediated cleavage events. These assay systems are widely utilized in basic research, drug discovery workflows, and the functional characterization of serine protease activity under various experimental conditions.

1. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

2. Emu oil in combination with other active ingredients for treating skin imperfections

3. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

4. Glucagonlike peptide 2 analogue teduglutide: stimulation of proliferation but reduction of differentiation in human Caco-2 intestinal epithelial cells

5. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency